Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India

Mycoses

Volumn 57, Issue 9, 2014, Pages 544-552

  Sharma, Cheshta ^a   Muralidhar, Sumathi ^b   Xu, Jianping ^c   Meis, Jacques F ^d,e   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c MCMASTER UNIVERSITY   (Canada)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Antifungal susceptibility testing; Candida africana; India; Multilocus sequence typing; Vulvovaginal candidiasis

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; CLOTRIMAZOLE; FLUCONAZOLE; FLUCYTOSINE; ISAVUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; FUNGAL PROTEIN; RIBOSOMAL SPACER DNA; RIBOSOME DNA; RIBOSOME RNA; RNA, RIBOSOMAL, 26S;

AFRICA; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA AFRICANA; FEMALE; FUNGUS ISOLATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; VAGINA CANDIDIASIS; ADOLESCENT; ADULT; CANDIDIASIS, VULVOVAGINAL; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; PHYLOGENY; TEMPERATURE; YOUNG ADULT;

CANDIDA AFRICANA;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CLUSTER ANALYSIS; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; FEMALE; FUNGAL PROTEINS; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; MYCOLOGICAL TYPING TECHNIQUES; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, RIBOSOMAL; SEQUENCE ANALYSIS, DNA; TEMPERATURE; YOUNG ADULT;

EID: 84905721098     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12193     Document Type: Article

References (30)

1. Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses 2001; 44: 437-45.
2. Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses 2011; 54: 475-86.
3. Tietz HJ, Küssner A, Thanos M, De Andrade MP, Presber W, Schönian G. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J Clin Microbiol 1995; 33: 2462-5.
4. Romeo O, Criseo G. Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana. J Clin Microbiol 2009; 47: 212-4.
5. Romeo O, Criseo G. First molecular method for discriminating between Candida africana, Candida albicans and Candida dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis 2008; 62: 230-3.
6. Borman AM, Szekely A, Linton CJ, Palmer MD, Brown P, Johnson EM. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol 2013; 51: 967-72.
7. Al-Hedaithy SSA, Fotedar R. Recovery and studies on chlamydospores-negative Candida albicans isolated from clinical specimens. Med Mycol 2002; 40: 301-6.
8. Odds FC, Bougnoux ME, Shaw DJ et al. Molecular phylogenetics of Candida albicans. Eukaryot Cell 2007; 6: 1041-52.
9. Alonso-Vargas R, Elorduy L, Eraso E et al. Isolation of Candida africana, probable atypical strains of Candida albicans, from a patient with vaginitis. Med Mycol 2008; 46: 167-70.
10. Romeo O, Criseo G. Morphological, biochemical and molecular characterisation of the first Italian Candida africana isolate. Mycoses 2009; 52: 454-7.
11. Nnadi NE, Ayanbimpe GM, Scordino F et al. Isolation and molecular characterization of Candida africana from Jos. Nigeria. Med Mycol 2012; 50: 765-7.
12. Dieng Y, Sow D, Ndiaye M et al. Identification of three Candida africana strains in Senegal. J Mycol Med 2012; 22: 335-40.
13. Hazen K (2013) Novel yeast, originally detected in Africa, now isolated from women in the United States. In: The 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sep 10-13; Denver, CO, USA
14. Romeo O, Tietz HJ, Criseo G. Candida africana: Is it a fungal pathogen? Curr Fungal Infect Rep 2013; 7: 192-7.
15. Ciardo DE, Schär G, Böttger EC, Altwegg M, Bosshard PP. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol 2006; 44: 77-84.
16. Forche A, Schönian G, Gräser Y, Vilgalys R, Mitchell TG. Genetic structure of typical and atypical populations of Candida albicans from Africa. Fungal Genet Biol 1999; 28: 107-25.
17. Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-23.
18. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, (eds), PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, 1990: 315-22.
19. Bougnoux ME, Tavanti A, Bouchier C et al. Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol 2003; 41: 5265-6.
20. Tavanti A, Gow NA, Senesi S, Maiden MC, Odds FC. Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol 2003; 41: 3765-76.
21. Chowdhary A, Lee-Yang W, Lasker BA, Brandt ME, Warnock DW, Arthington-Skaggs BA. Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates of Candida albicans. Med Mycol 2006; 44: 405-17.
22. Swofford DL (2002) PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts.
23. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition, M27-A3. Wayne, USA, PA: CLSI, 2008.
24. Sharma C, Wankhede S, Muralidhar S et al. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India. Diagn Microbiol Infect Dis 2012; 76: 46-50.
25. Gumral R, Sancak B, Guzel AB, Saraçli MA, Ilkit M. Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia 2011; 172: 73-6.
26. Yazdanpanah A, Khaithir TM. Issues in identifying germ tube positive yeasts by conventional methods. J Clin Lab Anal 2014; 28: 1-9.
27. Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell 2008; 7: 1075-84.
28. Sampaio P, Nogueira E, Loureiro AS, Delgado-Silva Y, Correia A, Pais C. Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents. Antonie Van Leeuwenhoek 2009; 96: 395-404.
29. Romeo O, De Leo F, Criseo G. Adherence ability of Candida africana: a comparative study with Candida albicans and Candida dubliniensis. Mycoses 2011; 54: e57-61.
30. Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses 2004; 47: 136-42.